Calliditas Therapeutics AB financial statements, including revenue, expenses, profit, and loss
The total revenue of CALT for the last quarter is 42.33 M USD, and it's 55.35% higher compared to the previous quarter. The net income of Q4 23 is -1.72 M USD.